nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

06.07.2020

Advance of antithrombotic treatment in patients with cerebral microbleed

verfasst von: Zhiying Chen, Yuchuan Ding, Xunming Ji, Xiaoping Yin, Ran Meng

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

With the elder proportion increasing and the antithrombotic agents widely using as well as the newly magnetic resonance imaging sequence emerging, the detection rate of cerebral microbleed (CMB) is gradually raising in recent years. As we all know that CMB mainly reflects the severity of deeply small vessel lesions, which predicts hemorrhagic transformation. Whereby, to some patients with both CMB and remarkable antithrombotic indication, treatment becomes a dilemma. We have to face the challenge of weighing the pros and cons of both drug indication and bleeding risk when making a proper decision for patients. This study summarized recent advance on CMB diagnosis and treatment, to provide a useful reference to physicians in their clinical practice.

Wu Y, Chen T (2016) An up-to-date review on cerebral microbleeds. J Stroke Cerebrovasc Dis 25:1301–1306. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.03.005CrossRefPubMed

Mazurek M, Papuc E, Rejdak K (2018) Brain microbleeds: definition, pathophysiology and the consequences. Wiad Lek 71:408–412PubMed

Charidimou A, Turc G, Oppenheim C, Yan S, Scheitz JF, Erdur H et al (2017) Microbleeds, cerebral hemorrhage, and functional outcome after stroke thrombolysis. Stroke 48:2084–2090. https://doi.org/10.1161/STROKEAHA.116.012992CrossRefPubMed

Baykara E, Gesierich B, Adam R, Tuladhar AM, Biesbroek JM, Koek HL et al (2016) A novel imaging marker for small vessel disease based on skeletonization of white matter tracts and diffusion histograms. Ann Neurol 80:581–592. https://doi.org/10.1002/ana.24758CrossRefPubMed

Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R et al (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822–838. https://doi.org/10.1016/S1474-4422(13)70124-8CrossRefPubMedPubMedCentral

Charidimou A, Shams S, Romero JR, Ding J, Veltkamp R, Horstmann S et al (2018) Clinical significance of cerebral microbleeds on MRI: a comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1). Int J Stroke 13:454–468. https://doi.org/10.1177/1747493017751931CrossRefPubMedPubMedCentral

Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM et al (2011) Incidence of cerebral microbleeds in the general population: the Rotterdam scan study. Stroke 42:656–661. https://doi.org/10.1161/STROKEAHA.110.607184CrossRefPubMed

Charidimou A, Boulouis G, Shams S, Calvet D, Shoamanesh A (2017) Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: preliminary meta-analysis of cohorts and anticoagulation decision schema. J Neurol Sci 378:102–109. https://doi.org/10.1016/j.jns.2017.04.042CrossRefPubMed

Han F, Zhai FF, Wang Q, Zhou LX, Ni J, Yao M et al (2018) Prevalence and risk factors of cerebral small vessel disease in a Chinese population-based sample. J Stroke 20:239–246. https://doi.org/10.5853/jos.2017.02110CrossRefPubMedPubMedCentral

10.

Yubi T, Hata J, Ohara T, Mukai N, Hirakawa Y, Yoshida D et al (2018) Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community. Neurol Clin Pract 8:223–231. https://doi.org/10.1212/CPJ.0000000000000464CrossRefPubMedPubMedCentral

11.

Cordonnier C, Al-Shahi SR, Wardlaw J (2007) Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 130:1988–2003. https://doi.org/10.1093/brain/awl387CrossRefPubMed

12.

Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH et al (2009) Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam scan study. Arch Neurol 66:714–720. https://doi.org/10.1001/archneurol.2009.42CrossRefPubMed

13.

Naka H, Nomura E, Kitamura J, Imamura E, Wakabayashi S, Matsumoto M (2013) Antiplatelet therapy as a risk factor for microbleeds in intracerebral hemorrhage patients: analysis using specific antiplatelet agents. J Stroke Cerebrovasc Dis 22:834–840. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.06.001CrossRefPubMed

14.

Liu S, Li C (2015) Antiplatelet drug use and cerebral microbleeds: a meta-analysis of published studies. J Stroke Cerebrovasc Dis 24:2236–2244. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.05.022CrossRefPubMed

15.

Wang DN, Hou XW, Yang BW, Lin Y, Shi JP, Wang N (2015) Quantity of cerebral microbleeds, antiplatelet therapy, and intracerebral hemorrhage outcomes: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 24:2728–2737. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.08.003CrossRefPubMed

16.

Charidimou A, Karayiannis C, Song TJ, Orken DN, Thijs V, Lemmens R et al (2017) Brain microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF. Neurology 89:2317–2326. https://doi.org/10.1212/WNL.0000000000004704CrossRefPubMed

17.

Cheng Y, Wang Y, Song Q, Qiu K, Liu M (2019) Use of anticoagulant therapy and cerebral microbleeds: a systematic review and meta-analysis. J Neurol. https://doi.org/10.1007/s00415-019-09572-xCrossRefPubMedPubMedCentral

18.

Liang Y, Song Q, Jiao Y, Lin J, Qu H, Zhao S et al (2018) Cerebral microbleeds and the safety of anticoagulation in ischemic stroke patients: a systematic review and meta-analysis. Clin Neuropharmacol 41:202–209. https://doi.org/10.1097/WNF.0000000000000306CrossRefPubMed

19.

Lioutas VA, Goyal N, Katsanos AH, Krogias C, Zand R, Sharma VK et al (2019) Microbleed prevalence and burden in anticoagulant-associated intracerebral bleed. Ann Clin Transl Neurol 6:1546–1551. https://doi.org/10.1002/acn3.50834CrossRefPubMedPubMedCentral

20.

Orken DN, Uysal E, Timer E, Kuloglu-Pazarci N, Mumcu S, Forta H (2013) New cerebral microbleeds in ischemic stroke patients on warfarin treatment: two-year follow-up. Clin Neurol Neurosurg 115:1682–1685. https://doi.org/10.1016/j.clineuro.2013.03.004CrossRefPubMed

21.

Yokoyama M, Mizuma A, Terao T, Tanaka F, Nishiyama K, Hasegawa Y et al (2019) Effectiveness of nonvitamin K antagonist oral anticoagulants and warfarin for preventing further cerebral microbleeds in acute ischemic stroke patients with nonvalvular atrial fibrillation and at least one microbleed: CMB-NOW multisite pilot trial. J Stroke Cerebrovasc Dis 28:1918–1925. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.03.050CrossRefPubMed

22.

Hori S, Hori E, Shibata T, Umemura K, Okamoto S, Kubo M et al (2019) Correlation between cerebral microbleeds and vulnerable plaque in patients with severe carotid artery stenosis; comparative magnetic resonance imaging study. J Stroke Cerebrovasc Dis 28:104300. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.07.016CrossRefPubMed

23.

Soo YO, Siu DY, Abrigo J, Yu S, Ng N, Ahuja AT et al (2012) Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke 43:1532–1536. https://doi.org/10.1161/STROKEAHA.111.626853CrossRefPubMed

24.

Gao Y, Nie K, Duan Z, Wang S, Ma G, Zhang X et al (2019) A follow-up study of cerebral microbleeds in patients who received stents for symptomatic cerebral artery stenosis. Ann Vasc Surg 58:338–346. https://doi.org/10.1016/j.avsg.2018.11.031CrossRefPubMed

25.

Seet RC, Rabinstein AA (2012) Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Cerebrovasc Dis 34:106–114. https://doi.org/10.1159/000339675CrossRefPubMed

26.

Zand R, Tsivgoulis G, Singh M, Mccormack M, Goyal N, Ishfaq MF et al (2017) Cerebral microbleeds and risk of intracerebral hemorrhage post intravenous thrombolysis. J Stroke Cerebrovasc Dis 26:538–544. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.127CrossRefPubMed

27.

Arca KN, Demaerschalk BM, Almader-Douglas D, Wingerchuk DM, O’Carroll CB (2019) Does high cerebral microbleed burden increase the risk of intracerebral hemorrhage after intravenous tissue plasminogen activator for acute ischemic stroke? Neurologist 24:40–43. https://doi.org/10.1097/NRL.0000000000000228CrossRefPubMed

28.

Kelly AG, Holloway RG (2018) Guideline: the AHA/ASA made 217 recommendations for early management of acute ischemic stroke in adults. Ann Intern Med 168:C63. https://doi.org/10.7326/ACPJC-2018-168-12-063CrossRef

29.

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2018) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. https://doi.org/10.1161/STR.0000000000000158CrossRefPubMed

30.

Al-Shahi SR, Minks DP, Mitra D, Rodrigues MA, Bhatnagar P, du Plessis JC et al (2019) Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial. Lancet Neurol. 18:643–652. https://doi.org/10.1016/S1474-4422(19)30184-XCrossRef

Titel: Advance of antithrombotic treatment in patients with cerebral microbleed
verfasst von: Zhiying Chen
Yuchuan Ding
Xunming Ji
Xiaoping Yin
Ran Meng
Publikationsdatum: 06.07.2020
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 2/2021
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02213-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Pulmonary Embolism Response Team activation during the COVID-19 pandemic in a New York City Academic Hospital: a retrospective cohort analysis

Correction to: Acute pulmonary embolism in COVID-19 related hypercoagulability

Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar

Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis

Characteristics of aged ischemic stroke patients indicative of cardioembolism

Role of prothrombin 19911 A>G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort study